eGenesis, Inc. Full-time
New York Β· 1 people tracked
Investment thesis
eGenesis is a biotechnology company, not an investment firm, that uses genome engineering to develop human-compatible pig organs for transplantation, targeting kidney, liver, and heart failure. The FDA has cleared its IND application for a clinical trial of its genetically engineered porcine kidney in patients with end-stage kidney disease.
Team Β· 1 people
from the firm's websiteFrequently asked questions
- What sectors does eGenesis, Inc. Full-time focus on?
- eGenesis, Inc. Full-time focuses on Biotech.
- Where is eGenesis, Inc. Full-time located?
- eGenesis, Inc. Full-time is headquartered in New York, US.
Images
Similar investors
8VC is a technology investment firm that builds and invests in ambitious companies across sectors including life sciences, healthcare, manufacturing, enterprise, logistics, and defense.
ACT Venture Capital is an independent Irish venture capital firm that invests β¬1 million to β¬15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
Andreessen Horowitz's Strategic Partnerships page describes collaborations that connect its portfolio companies with established institutions to help scale and deploy their technology.
B Capital Group is a multi-stage venture capital firm that backs founders across the company-building lifecycle, investing in technology, healthcare, and energy & resilience sectors.